Blood Transfusion Diagnostics Market by Technology, Product type, Application, End-user and Geography. Market leaders are Abbott Diagnostics. Novartis, Becton Dickinson, BAG healthcare, DiaSorin, Fujirebio, Grifols, Siemens, Quidel, Hologic, Biokit, Bio-R

Blood transfusion is a medical procedure in which the blood is donated to the patient through a narrow tube that is placed within the vein. The blood transfusion is a life-saving procedure which helps in replacing the blood loss during surgery or injury. The transfusion process is done even if the patient’s body is not capable of make blood owing to illness.

The key factors leading to the growth of blood transfusion diagnostics market are-
• Increased cases of infectious diseases
• Growing blood transfusion procedures
• Technological development
• Automation of blood banks

Although, the danger involved in the blood transfusion in cases of infectious diseases will impede the growth of blood transfusion diagnostics market.

Market summary:
The global blood transfusion diagnostics market solely depends on the increase in number of blood transfusion required by hospitals in surgeries and blood loss. Increased governments initiatives is helping to grow the diagnostics market for blood transfusion through good manufacturing practices. With technological advancements, donations and other schemes is positively affecting the blood transfusion diagnostics market. With increased need for diagnosis prior to blood transfusion is increased in blood banks throughout the global. The set up for diagnostics laboratories and hospital laboratories will be growing the market for blood transfusion diagnostics.

Read more Insights at https://www.precisionbusinessinsights.com/market-reports/blood-transfusion-diagnostics-market/

Regional analysis:
Factors such as increased cases of blood-related disorders and increasing awareness among the affected patients is helping the North American market to top the market growth in this region. Adoption of newer and advanced treatment procedures such as nucleic acid amplification in blood and blood products transfusion is growing the market.

Following the path, Asia-Pacific is slowly picking up the pace for its larger number of patient pool.

Notable market development:
Erytra Eflexis was launched by Grifols, in 2017, a latest advancement in scalable blood typing solutions adapting to various laboratory workflow pattern.

Avail free sample report at https://bit.ly/2TuWUVz

Some of the key players in the global blood transfusion diagnostics market include:
• Abbott Diagnostics (U.S)
• Novartis AG (Switzerland)
• Becton Dickinson (U.S)
• BAG healthcare (Germany)
• DiaSorin (Italy)
• Fujirebio (Belgium)
• Grifols (Spain)
• Siemens (Germany)
• Quidel (U.S)
• Hologic/Gen-Probe (U.S)
• Biokit (Spain)
• Bio-Rad (U.S)
• Beckman Coulter (U.S)
• Quotient Limited (U.S)
• Diagast (France)

The global blood transfusion diagnostics market is divided into technology, product type, end-users and geographical regions.

By technology
• ELISA
• Nucleic Acid Amplification
• Rapid Test
• Real-Time PCR
• Fluorescence Assay
• Western Blot

By product type
• Platelets
• Red Blood Cells
• Albumin

By application
• Disease Screening
• Blood Grouping
• Others

By end users
• Hospitals
• Blood Banks
• Diagnostic Laboratories

By geographical regions
• North America
• Latin America
• Asia Pacific
• The Middle East and Africa
• Europe

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact us
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

This release was published on openPR.